Showing results (81-90 of 510) with videos related to
Sort By:
Pageof 51
Current Gene Therapy|February 22, 2012
Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiencyClaudia A Montiel-Equihua, Adrian J Thrasher, H Bobby GasparEuropean Journal of Cell Biology|March 21, 2006
The leukocyte podosomeYolanda Calle, Siobhan Burns, Adrian J Thrasher, et al.Disease Markers|December 24, 2010
The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell functionMichael P Blundell, Austen Worth, Gerben Bouma, et al.Expert Opinion on Biological Therapy|March 21, 2008
Gene therapy of inherited immunodeficienciesGiorgia Santilli, Susannah I Thornhill, Christine Kinnon, et al.Human Gene Therapy|June 14, 2012
Gene therapy for primary immunodeficienciesChristine Rivat, Giorgia Santilli, H Bobby Gaspar, et al.Journal of Clinical Immunology|August 1, 2002
Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemiaCornelia Brunner, Hans Wolfgang Kreth, Hans D Ochs, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangementWinifred Huang, Hans D Ochs, Bo Dupont, et al.Journal of Clinical Immunology|November 1, 2011
Primary immunodeficiency diseases associated with neurologic manifestationsSoodabeh Fazeli Dehkordy, Asghar Aghamohammadi, Hans D Ochs, et al.The Journal of Pathology|October 21, 2004
Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cellsYolanda Calle, Hsiu-Chuan Chou, Adrian J Thrasher, et al.British Journal of Haematology|September 4, 2010
Recent advances in the understanding of genetic defects of neutrophil number and functionGerben Bouma, Phil J Ancliff, Adrian J Thrasher, et al.Pageof 51